Continental Advisors’s Cardinal Health CAH Stock Holding History

Continental Advisors’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-47,000	Closed	-$3.14M	–	133
2013 Q4	$3.14M	Buy	+47,000	New	+$2.87M	0.68%	35

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Continental Advisors's CAH Position: Q2 2025 in Review

Continental Advisors sold out of Cardinal Health (CAH) in Q2 2025, closing a stake of 13,184 shares — an estimated $1.82M sold.

Continental Advisors first reported a position in CAH in Q2 2013 and held it in 48 quarters. The position peaked at $7.97M in Q4 2021. 1,253 funds tracked by Wall St. Rank hold CAH as of Q2 2025.

Continental Advisors reported no remaining Cardinal Health position as of Q2 2025 after selling out during the quarter.
Continental Advisors sold 13,184 Cardinal Health shares in Q2 2025, an estimated $1.82M.
Continental Advisors first reported a position in Cardinal Health in Q2 2013 and held it in 48 quarters.
Continental Advisors's Cardinal Health position peaked at $7.97M in Q4 2021.
1,253 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2025.

Based on Continental Advisors's 13F filing for Q2 2025, filed 19 Aug 2025.